Section

Policy

IRA, state PBM reform, Medicare, and regulatory action

PolicyDrug Channels ↗

List Price Reductions Will Deflate the Gross-to-Net Bubble–and Threaten Pharmacy and 340B Profits from IRA-Negotiated Drugs (rerun)

This week, I’m rerunning some popular posts while we prepare for Friday’s live video webinar: PBM Industry Upd…

Apr 8, 2026

← Newer Page 19